title: Lymphoma of the skin.
abstract: This chapter describes the various ways in which the non-Hodgkin's lymphomas can involve the skin, how these diseases should be assessed, standard treatments available in 2002, and new directions in research. The goal of the session is to succinctly review recent developments in lymphoma classification and treatment as they apply to the unique aspects of lymphoma when manifest in the skin. In Section I, Dr. Eric Hsi reviews the special characteristics of the lymphomas seen when they proliferate in the skin and the application of the new World Health Organization classification system to the cutaneous lymphomas, emphasizing the unique challenges of recognizing and correctly classifying these diseases. He summarizes the evidence in favor of including the skin lymphomas in the overall lymphoma classification scheme and concludes with a practical description of the specific skin lymphoma entities. In Section II, Dr. Joseph Connors describes the current optimal treatment of the B-cell lymphomas when they present in or metastasize to the skin. Building on the classification scheme described by Dr. Hsi, Dr. Connors outlines a treatment approach based on current understanding of pathophysiology of these diseases and application of each of the effective modalities available for cutaneous lymphoma including radiation, chemotherapy, and immunotherapy. In Section III, Dr. Francine Foss concludes the session with a discussion of the different T-cell lymphomas that start in or spread to the skin concentrating on mycosis fungoides, cutaneous anaplastic large cell lymphoma and peripheral T-cell lymphoma. She includes comments on the newer anti-T-cell chemo- and immuno-therapeutics focusing on agents and techniques specific for cutaneous T-cell lymphomas.
authors.affiliation: Vancouver Clinic, BC Cancer Agency, Canada.
authors.forename: Joseph M
authors.initials: JM
authors.lastname: Connors
authors.forename: Eric D
authors.initials: ED
authors.lastname: Hsi
authors.forename: Francine M
authors.initials: FM
authors.lastname: Foss
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D008223:Lymphoma / Q000145:classification / Q000473:pathology* / Q000628:therapy; D016393:Lymphoma, B-Cell / Q000145:classification / Q000473:pathology / Q000628:therapy; D016410:Lymphoma, T-Cell, Cutaneous / Q000145:classification / Q000473:pathology / Q000628:therapy; D012878:Skin Neoplasms / Q000145:classification / Q000473:pathology* / Q000628:therapy
chemical_list: D000970:Antineoplastic Agents